An FDA independent advisory panel recommended that a blood test to detect colon cancer be approved. Here's what you need to know.
The Shield blood test was able to accurately detect colorectal cancer about 83 percent of the time. It was able to detect precancerous lesions about 13 percent of the time. The prescription-only ...
May 23 (UPI) --A panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new blood test to detect colon and rectal cancer despite concerns over the test's accuracy.
Patients with early-stage ovarian cancer may have detectable changes in the immune cells in their blood. Immune signatures in ...
Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests, are a new method of detecting cancer early.
Opinion: Medicare must provide immediate coverage for new preventive care tools and services for treating cancer.
In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal ...
Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal ...
In a recent study published in Cancer Discovery, researchers developed and validated a blood-based, cell-free ...
Backed by his billionaire brother, Lucence Life Sciences founder Min-Han Tan won Medicare coverage for his cancer-detecting ...